台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股▼0.22%
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
旭富 (4119)籌碼相關-富邦-桃園 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-桃園 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/14183.5000.0084.0012700.37%
2025/01/13184.004.983.9383.90-3.9269-1.45%
2025/01/080.290.0000.0089.800.22470.08%
2025/01/0700.00189.9089.80-1247-0.40%
2024/12/2600.00190.9091.00-1250-0.40%
2024/12/200.189.9000.0089.800.12470.04%
2024/12/1700.00290.5090.20-2243-0.82%
2024/12/160.390.0000.0090.300.32420.14%
2024/12/131.191.0000.0090.601.12380.44%
2024/12/1100.00093.9094.0002290.00%
2024/12/1000.00593.6694.00-5225-2.21%
2024/12/09593.4200.0093.4052242.22%
2024/12/0400.00797.4397.80-7216-3.23%
2024/12/03297.5000.0097.8022160.92%
2024/11/29596.141196.0496.20-6199-3.00%
2024/11/2700.00195.0094.70-1197-0.51%
2024/11/26196.301096.5195.50-9193-4.66%
2024/11/25197.60297.7597.60-1187-0.53%
2024/11/220.597.9000.0097.500.51810.28%
2024/11/21497.3000.0098.0041782.24%
2024/11/20398.431.597.9397.801.51720.89%
2024/11/1800.001295.3896.00-12151-7.91%
2024/11/15595.261394.8895.50-8147-5.40%
2024/11/14194.8000.0094.9011420.70%
2024/11/13695.62095.6096.0061364.40%
2024/11/12194.2000.0094.3011230.81%
2024/11/040.190.0000.0089.500.11040.10%
2024/11/0100.000.289.9090.00-0.2114-0.21%
2024/10/3000.00289.4589.60-2114-1.74%
2024/10/2800.00189.4089.60-1115-0.86%
2024/10/2500.00189.9089.40-1117-0.85%
2024/10/2400.00189.9089.60-1118-0.84%
2024/10/230.689.070.189.4089.000.51180.45%
2024/10/1800.000.190.2089.70-0.1124-0.05%
2024/10/1400.00390.5090.50-3133-2.25%
2024/10/110.590.8000.0091.000.51330.37%
2024/10/07391.7000.0092.2031352.21%
2024/09/3000.00189.3089.80-1133-0.75%
2024/09/0500.00287.7086.50-2160-1.25%
2024/08/290.289.00288.1088.50-1.8172-1.04%
2024/08/28289.0000.0088.9021721.16%
2024/08/0600.00685.8588.90-6218-2.75%
2024/07/310.191.0000.0091.200.12040.02%
2024/07/0300.00591.2091.40-5206-2.42%
2024/06/13190.0000.0090.0012120.47%
2024/06/11291.60190.4090.2012140.47%
2024/05/31192.50092.1092.0012300.43%
2024/05/29192.1000.0092.3012340.43%
2024/05/28193.1000.0092.5012350.42%
2024/05/2200.00192.0092.40-1235-0.42%
2024/05/2100.000.192.4992.10-0.1235-0.03%
2024/05/20193.5000.0093.4012330.43%
2024/05/17393.90193.8093.9022300.87%
2024/05/16292.3000.0092.5022250.89%
2024/05/150.191.4000.0091.500.12220.03%
2024/05/1000.000.290.5090.90-0.2240-0.10%
2024/05/09088.8000.0088.5002430.01%
2024/05/0700.00088.0088.1002420.00%
2024/04/29189.1000.0089.2012460.41%
2024/04/2500.000.388.0088.50-0.3245-0.13%
2024/04/1900.00186.3086.40-1254-0.39%
2024/04/02189.1000.0088.6012590.39%
2024/03/2100.00087.8087.7002740.00%
2024/03/1800.000.187.0086.90-0.1284-0.04%
2024/03/14187.1000.0087.2012860.35%
2024/03/08592.1000.0090.4052731.83%
2024/03/0700.000.390.5090.50-0.3269-0.09%
2024/02/20191.0000.0091.0012840.35%
2024/02/19191.001.190.9391.50-0.1285-0.03%
2024/02/1500.000.290.1089.90-0.2293-0.07%
2024/02/050.291.2000.0091.100.22910.07%
2024/02/01092.5000.0092.3002990.01%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章